Improving Maternal Cardiovascular Outcomes Through the Implementation of a Hypertensive Disorders of Pregnancy Bundle in Nigeria
The goal of this interventional study is to learn from patients and healthcare providers at 4 health institutions (study sites) in Abuja and Kano in Nigeria what ways to best develop the content of a Hypertensive Disorders of Pregnancy ( HDP) Management package for pregnant women, and evaluate the effectiveness of implementing this package in improving cardiovascular health of pregnant women. The main question it aims to answer is: Will a contextualized home BP monitoring program lead to better BP control among…
Conditions studied
Hypertensive Disorder of Pregnancy
About this study
The goal of this interventional study is to learn from patients and healthcare providers at 4 health institutions (study sites) in Abuja and Kano in Nigeria what ways to best develop the content of a Hypertensive Disorders of Pregnancy ( HDP) Management package for pregnant women, and evaluate the effectiveness of implementing this package in improving cardiovascular health of pregnant women. The main question it aims to answer is: Will a contextualized home BP monitoring program lead to better BP control among patients with HDP in Nigeria?
Interventions
- Other: Hypertension Disorders of Pregnancy (HDP) Implementation Bundle — The HDP Implementation Bundle will consist of 4 main blocks namely; patient education, home BP monitoring, a contextualized follow-up protocol and provision of free anti-hypertensives if need. Collectively, these will lead to design and development of a contextualized home BP monitoring program.
Primary outcomes
- Between group difference in change in systolic BP from baseline to 6-week follow-up (Baseline to 6 weeks)
Eligibility information
Study locations
- National Hospital, Abuja, Abuja, Nigeria
- University of Abuja Teaching Hospital, Abuja, Nigeria
- Aminu Kano Teaching Hospital, Kano, Nigeria
- Murtala Muhammad Specialist Hospital, Kano, Nigeria
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.